Braskem S.A. (BAK) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BAK Revenue Growth
Revenue Breakdown (FY 2024)
BAK's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
BAK Revenue Analysis (2013–2024)
As of May 8, 2026, Braskem S.A. (BAK) generated trailing twelve-month (TTM) revenue of $73.77 billion, reflecting significant decline in growth of -18.7% year-over-year. The most recent quarter (Q3 2025) recorded $17.30 billion in revenue, down 3.1% sequentially.
Looking at the longer-term picture, BAK's 5-year compound annual growth rate (CAGR) stands at +8.1%, indicating steady revenue expansion. The company achieved its highest annual revenue of $105.63 billion in 2021.
Revenue diversification analysis shows BAK's business is primarily driven by Benzene Toluene And Xylene (30%), Ethylene Propylene (29%), and Other 1 (17%).
When compared to Basic Materials sector peers including LYB (-34.8% YoY), WLK (-8.6% YoY), and OLN (+2.6% YoY), BAK has underperformed the peer group in terms of revenue growth. Compare BAK vs LYB →
BAK Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BAKCurrent | $73.8B | -18.7% | +8.1% | 1.3% | |
 LYB | $30.2B | -34.8% | +1.7% | -1.1% | |
 WLK | $11.2B | -8.6% | +8.3% | -14.1% | |
 OLN | $6.8B | +2.6% | +3.3% | 1.7% | |
 TROX | $2.9B | -3.9% | +1.0% | -0.7% | |
 AVNT | $3.3B | +1.3% | +0.1% | 6.2% |
BAK Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $77.41B | +9.7% | $6.00B | 7.7% | $1.01B | 1.3% |
| 2023 | $70.57B | -26.9% | $3.02B | 4.3% | $-1,750,000,000 | -2.5% |
| 2022 | $96.52B | -8.6% | $11.36B | 11.8% | $6.11B | 6.3% |
| 2021 | $105.63B | +80.4% | $32.06B | 30.3% | $27.18B | 25.7% |
| 2020 | $58.54B | +11.9% | $11.10B | 19.0% | $7.02B | 12.0% |
| 2019 | $52.32B | -9.8% | $6.44B | 12.3% | $169.1M | 0.3% |
| 2018 | $58.00B | +17.7% | $11.59B | 20.0% | $8.30B | 14.3% |
| 2017 | $49.26B | +3.4% | $12.86B | 26.1% | $9.36B | 19.0% |
| 2016 | $47.66B | +0.8% | $12.72B | 26.7% | $5.95B | 12.5% |
| 2015 | $47.28B | +2.7% | $10.38B | 22.0% | $7.05B | 14.9% |
See BAK's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BAK Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BAK vs LIN
Side-by-side business, growth, and profitability comparison vs Linde plc.
Start ComparisonBAK — Frequently Asked Questions
Quick answers to the most common questions about buying BAK stock.
Is BAK's revenue growth accelerating or slowing?
BAK revenue declined -18.7% year-over-year, contrasting with the 5-year CAGR of +8.1%. TTM revenue fell to $73.8B. This reverses the prior growth trend.
What is BAK's long-term revenue growth rate?
Braskem S.A.'s 5-year revenue CAGR of +8.1% reflects the variable expansion pattern. Current YoY growth of -18.7% is below this long-term average.
How is BAK's revenue distributed by segment?
BAK reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.